Maryland-based vaccine manufacturer Novavax released preliminary results from an early clinical phase study of its combination Covid/flu vaccine.
On Wednesday, The results found that the combination vaccine produced immune responses in patients that were comparable with those of its stand-alone flu and Covid vaccines. The company also found the vaccine formulation to be safe, with mostly mild side effects.
“We’re encouraged by these data and the potential path forward for a combination Covid-19-influenza vaccine as well as stand-alone vaccines for influenza and Covid-19,” Gregory Glenn, Novavax’s president of R&D, said in a statement. Novavax’s vaccine differs from the mRNA vaccines developed by Pfizer, BioNTech and Moderna. Its vaccines use nanoparticles that mimic proteins from the coronavirus or influenza virus . The nanoparticles are injected into patients along with an adjuvant, which is a chemical that helps stimulate the immune system, which causes the patients to develop antibodies against Covid and flu.
The company’s flu vaccine is currently in phase 3 trials. At a media briefing on Wednesday morning, Novavax’s chief medical officer Filip Dubovsky said data from those trials so far show higher antibody responses for patients with Novavax’s vaccine against multiple strains of flu compared to patients who received an approved flu vaccine.
Novavax’s Covid vaccine has been authorized for use in over 40 countries around the world, including the EU and. The company applied for emergency authorization with the FDA in January.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Novavax Says Vaccine Targeting Covid and Flu Shows Promising Results in Early DataNovavax plans to move forward with a phase two trial this year to confirm the dosing levels, and a phase three during the 2023 flu season at the earliest.
Read more »
Princess cruise ship with COVID-positive guests, staff docks in Los AngelesA Grand Princess cruise ship where both staff and guests tested positive for COVID-19 onboard has arrived in Los Angeles.
Read more »
Princess Cruises ship docks in LA as passengers test positive for COVID-19The cruise industry and the local ports have been excited for what they said will be a huge year in 2022.
Read more »
Amazon claims worker was fired for 'bullying,' not protesting COVID safetyOn Monday, a judge ordered Amazon to reinstate a former warehouse employee and pay him two years' worth of lost wages.
Read more »
Novavax Says Vaccine Targeting Covid and Flu Shows Promising Results in Early DataNovavax plans to move forward with a phase two trial this year to confirm the dosing levels, and a phase three during the 2023 flu season at the earliest.
Read more »
Multi-Strain COVID-19 Vaccines Might Be Coming. Moderna Reports Results of Its First Combination ShotMulti-Strain COVID-19 Vaccines Might Be Coming, After Moderna Reports Promising Study Results
Read more »